1/77
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
MOA of Insulins?
Activates receptors & reduce circulating glucose
Insulin allergy involves which immunoglobulin?
IgE
Immune insulin resistance involves which immunoglobulin?
IgG
What are the 1st generation Sulfonylureas?
Tolbutamide
What are the 2nd generation sulfonylureas?
Glyburide
Glipizide
Glimepiride
MOA of sulfonylureas?
Inhibit K+ efflux through the channel = depolarization → voltage-gated calcium channel opens, calcium influx, & release of insulin + increase number of insulin receptors
Who shouldn’t use Glyburide?
Liver failure, chronic kidney disease patients, & obese patients
Which sulfonylurea binds to the receptor & becomes sequestered within the B cell?
Glyburide
Which Sulfonylurea, because of its shorter duration of action, is prefered in elderly & those with renal impairment & non-obese patients?
Glipizide
What can inhibit tolbutamide’s metabolism resulting in prolonged hypoglycemia?
Some sulfonamides (sulfisoxazole) & oral azole
What are contraindicatiions of sulfonylurea?
Pregnant & breast feeding mothers
What are the non-sulfonylureas?
Meglitinide analogs
Repaglinide
Nateglinide
What is a Meglitinide & its MOA?
Regulates K+-ATP channels in pancreatic beta cells
What are indications of meglitinide?
Best to control postprandial glucose bc of its rapid onset to avoid hypoglycemia
Patients with renal failure &/or the elderly
Monotherapy or with biguanides
MOA of nateglinide?
Stimulates rapid & transient release of insulin through closure of ATP-sensitive K+ channels
Why should repaglinide & nateglinide be taken with a meal specifically one with adequate carbs?
To reduce the chance of hypoglycemia - reduce postprandial rise in blood glucose
What is the T2D drug of choice?
Biguanides - metformin
MOA of Biguanides?
Reduces hepatic & renal gluconeogenesis (glucose production) & increases glucose uptake & utilization in skeletal muscle
Adverse effects of Biguanides?
GI effects - anorexia, nausea, vomiting, etc
Interferes with absorption of B12
Lactic acidosis (alcoholics)
Patients with renal or hepatic disease; alcohol (contra)
What are the thiazolidinediones?
Pioglitazone
Rosiglitazone
MOA of thiazolidinediones?
Regulate gene expression by binding to PPAR-y & PPAR-a
What drugs will cause no hypoglycemia?
Thiazolidinedione + Metformin
What can improve nonalcoholic fatty liver disease?
Thiazolidinediones
What drug:
Lowers TG & increases HDL without effecting total cholesterol & LDL
Reduces risk of stroke or MI in non-diabetic insulin-resistant patients
PPAR-a & PPAR-y activity
Pioglitazone
What drug:
Increases total cholesterol, HDL, & LDL without affecting TGs
Improves nonalcoholic fatty liver disease
Rosiglitazone
Adverse effects of Thiazolidindediones?
Fluid retention (insulin therapy patients)
HF
Macular edema
Loss of bone mineral densitiy - fracture
What are the a-Glucosidase inhibitors?
Acarbose
Miglitol
MOA of a-Glucosidase?
Competitively inhibits intestinal a-glucosidase enzymes which convert starch & disaccharides into monosaccharides in SI
Adverse effects of a-Glucosidase inhibitors?
GI issues
Hypoglycemia if used w/ secretagogues (sulfonylureas) (treat with glucose)
What are the amylin analogs?
Pramalintide
MOA of pramalintide?
Acts as a negative feedback on insulin secretion, & reduces glucagon secretion → slows gastric emptying & decreases appetite
What is pramlintide indicated for?
Patient with T1D presents with consistent postprandial hyperglycemia
Adverse effects of pramlintide include GI symptoms & hypoglycemia. How exactly does the drug cause hypoglycemia?
Slows gastric emptying so recovering can be problematic bc of the delay in absorption of fast-acting carbs
What are the bile acid sequestrants?
Colesvelam hydrochloride
MOA of colesevelam hydrochloride?
Lowers glucose through unknown mechs → may involve FXR (farnesoid X receptor) that has effects on cholesterol, glucose, & bile acid metabolism
Who is colesevelam hydrochloride indicated for?
Patients with T2D who have not achieved adequate control with diet & exercise or other glucose lowering medications
Lowers LDL-C in adults with with hyperlipidemia & pediatric patients with heterozygous familial hypercholesterolemia
What are adverse effects of colesevelam hydrochlorid?
GI issues
Exacerbate hypertriglycerimidemia, common in T2D patients
What are the dopamine agonists?
Bromocriptine
MOA of bromocriptine?
D2 (dopamine) receptor agonist, lowers glucose through unknown mech
Oral glucose in the SI stimuate the release of hormones called incretins. What are these incretins?
Glucagon-like peptide-1 (GLP-1)
Glucose-dependent insulinotropic peptide (GIP)
What is the role of incretins?
Regulate postprandial glucose regulation, stimulating insulin secretion in response to food ingestion
MOA of GLP-1s?
Stimulate insulin release & lower glucose levels
Glucose-dependent, so more glucose = more insulin
Lower risk for hypoglycemia
Suppresses glucagon secretion, delays gastric emptying, & decreases appetite
Reduces postprandial hyperglycemia
What degrades GLP-1 agonists?
DPP-4
Adverse effects of GLP-1 agonists?
Nausea, vomitting, diarrhea
Renal injury (exenatide)
Increased risk of pancreatitis
What shouldn’t be used in patient with a FH or PMH of medullary thyroid cancer or multiple endocrine neoplasia (MEN) syndrome type 2?
Exenatide & liraglutide
Which GLP-1 reduces A1C, causes weight loss, & has a low hypoglycemic risk?
Exenatide
Which GLP-1 has a half-life of 5 days & is indicated in to reduce major cardiovascular events?
Dulaglutide (trulicity)
Which GLP-1 is approved for weight loss in patients without T2D?
Liraglutide
Which GLP-1 has the longest half-life (1 week)?
Semaglutide (ozempic)
What are the DPP-4 inhibitors?
Alogliptin
Linagliptin
Saxagliptin
Sitagliptin
MOA of DPP-4 inhibitors?
Block degradation of GLP-1, increase insulin secretion, & suppress glucagon release
When alogliptin & linagliptin are added to _ it lowers A1C:
Metformin, sulfonylurea, or pioglitazone
Which DPP-4 inhibitors require a dosage adjustment in renal impaired patients?
Saxagliptin & sitagliptin
Adverse effects of DPP-4 inhibitors?
Nasopharyngitis/upper resp. tract infections
Anaphylaxis, angiodema, & skin conditions
Pancreatitis/hepatic failure
HF
Joint pain (severe arthralgia)
What are the SGLT-2 inhibitors?
Canagliflozin
Dapagliflozin
Empagliflozin
Ertugliflozin
MOA of SGLT-2 inhibitors & what it causes?
Blocks renal glucose resorption which causes glycosuria & lowers blood glucose& A1C levels, & contributes to modest weight loss
Adverse effects of SGLT-2 inhibitors?
Genital mycotic infections & UTI
Pyelonephritis & septicemia
Necrotizing fascitis of the perineum
Glycosuria = hypotension
Risk of breast & bladder cancer + decrease in bone mineral density
Euglycemic diabetic ketoacidosis
What does inhibition of SGLTs cause?
Glycosuria
Low blood glucose & A1C levels
Modest weight loss
2nd choice in patients with diabetic nephropathy or HR
Which drugs have moderate efficacy?
DPP-4 inihbitors & SGLT-2 inhibitors
What drugs have an increased risk for hypoglycemia?
Sulfonylureas & insulins
What drug is best for severe insulin resistance?
Pioglitazone
Weight gain medications?
Sulfonylureas, insulin, & pioglitazone
Weight neutral medications?
Metformin & DPP-4
Weight loss medications & cardiovascular benefits?
GLP-1 agonists & SGLT-2 inhibitors
SGLT-2 inhibitors reduce progression of what?
Diabetic nephropathy or HF
What drugs have shown improved cardiovascular outcomes?
Liraglutide, empagliflozin, & canagliflozin
What can a short acting secretagogue be helpful in?
Control glucose levels & reduce hyperglycemia after a carb-rich meal